Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Janice W. Smith"'
Autor:
Gary Gilmour, Dale M. Edgar, Francois Gastambide, Lorena Taboada, Beverly A. Heinz, Elaine Shanks, Brian G. Getman, Lourdes Prieto, Janice W. Smith, Lisa M. Broad, Thomas C. Britton, Keith A. Wafford, Adam M. Fivush, Mark D. Tricklebank, Andrew McCarthy, Ellen M. Colvin
Publikováno v:
Neuropharmacology. 64:224-239
The demonstrated functional interaction of metabotropic glutamate 5 (mGlu₅) receptors with N-methyl-d-aspartate (NMDA) receptors has prompted speculation that their activation may offer a potential treatment for aspects of schizophrenia. Developmen
Autor:
Mark J. Benvenga, Michael A. Statnick, Karen M. Knitowski, Julie Foss, Miguel A. Toledo, Alfonso Benito, Anke Post, Kirsti Lloyd, Michael Ansonoff, Alma Jiménez, Vanessa N. Barth, Maria Angeles Martinez-Grau, Janice W. Smith, Scott D. Gleason, Celia Lafuente, Linda M. Rorick-Kehn, John T. Catlow, Conception Pedregal, Nuria Diaz, Julie F. Falcone, Kjell A. Svensson, John E. Pintar, Steven Chaney, Xia Li, David L. McKinzie, Benjamin L. Adams, Jeffrey M. Witkin
Publikováno v:
Pharmacology Research & Perspectives
Nociceptin/Orphanin FQ (N/OFQ) is a 17 amino acid peptide whose receptor is designated ORL1 or nociceptin receptor (NOP). We utilized a potent, selective, and orally bioavailable antagonist with documented engagement with NOP receptors in vivo to ass
Autor:
Sofia I. H. Godinho, Rachel Butler, Stuart N. Peirson, Sheena Lee, Janice W. Smith, Kay E. Davies, Melanie V. Sobczyk, Achilleas Livieratos, Benjamin Edwards, Henrik Oster, Russell G. Foster, Peter L. Oliver, Johanna E. Chesham, Simon P. Fisher, Katharina Wulff, Michael H. Hastings, Elizabeth S. Maywood
Publikováno v:
Current Biology
Summary Sleep and circadian rhythm disruption has been widely observed in neuropsychiatric disorders including schizophrenia [1] and often precedes related symptoms [2]. However, mechanistic basis for this association remains unknown. Therefore, we i
Autor:
Janice W. Smith, Julie Foss, Kirstie J. Lloyd, Sophie Dix, Gary Gilmour, Francois Gastambide, Nadia Malik, Mark D. Tricklebank
Publikováno v:
Psychopharmacology. 217:255-269
N-methyl-d-Aspartate receptor (NMDAR) antagonists such as ketamine induce cognitive symptoms in man similar to those of schizophrenia and therefore might be useful as models of the disease in animals. However, it is unclear which NMDAR antagonist(s)
Autor:
Rebecca Mason, Michael W. Conway, Wendy T. Jones, Gary Gilmour, Sally Loomis, Elsa Y. Pioli, Sophie Dix, Shahram Shahabi, Mark D. Tricklebank, Janice W. Smith
Publikováno v:
Psychopharmacology. 205:203-216
Little attention has been paid to the relative equivalence of behavioural effects of NMDA receptor antagonists in rodents, with different compounds often used interchangeably to “model” aspects of schizophrenia in preclinical studies. To further
Autor:
Adrian J. Mogg, Philip G. Szekeres, Elisiana Tafi, Ian A. Pullar, Mark D. Tricklebank, Janice W. Smith, Eleanor Peacey
Publikováno v:
Psychopharmacology. 190:157-170
Nicotine produces behavioural effects that are potentially related to its interaction with diverse nicotinic acetylcholine receptor populations. Evidence from gene deletion studies suggests that the interoceptive stimulus properties of nicotine are m
Autor:
Gary, Gilmour, Lisa M, Broad, Keith A, Wafford, Thomas, Britton, Ellen M, Colvin, Adam, Fivush, Francois, Gastambide, Brian, Getman, Beverly A, Heinz, Andrew P, McCarthy, Lourdes, Prieto, Elaine, Shanks, Janice W, Smith, Lorena, Taboada, Dale M, Edgar, Mark D, Tricklebank
Publikováno v:
Neuropharmacology. 64
The demonstrated functional interaction of metabotropic glutamate 5 (mGlu₅) receptors with N-methyl-d-aspartate (NMDA) receptors has prompted speculation that their activation may offer a potential treatment for aspects of schizophrenia. Developmen
Publikováno v:
Psychopharmacology. 212(2)
The range of cognitive and psychotomimetic effects produced by antagonists of the N-methyl-D-aspartate (NMDA) receptor has lead to widespread usage of these molecules as pharmacological models of cognitive impairment for drug discovery. Historically,
Autor:
Janice W, Smith, Ian P, Stolerman
Publikováno v:
Handbook of experimental pharmacology. (192)
Drug discrimination methodology makes possible the objective, quantitative study of the perception of psychoactive drug effects in either human or animal subjects. Investigations of the nicotine discriminative stimulus complex have contributed to our
Autor:
Janice W. Smith, Ian P. Stolerman
Publikováno v:
Handbook of Experimental Pharmacology ISBN: 9783540692461
Drug discrimination methodology makes possible the objective, quantitative study of the perception of psychoactive drug effects in either human or animal subjects. Investigations of the nicotine discriminative stimulus complex have contributed to our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eee0a59c2e8996ad876c14d7e67dd8f2
https://doi.org/10.1007/978-3-540-69248-5_11
https://doi.org/10.1007/978-3-540-69248-5_11